Blue Water Vaccine stock continues downward slide in wake of private placement

Home » Blog » Blue Water Vaccine stock continues downward slide in wake of private placement
IPO Initial Public Offering

Blue Water Vaccine stock continues downward slide in wake of private placement


Mikko Lemola/iStock via Getty Images

Blue Water Vaccine (BWV) shares fell 11% Thursday afternoon, the day after it announced it had closed on a private placement priced at-the-market that raised $8M.

Shares of the vaccine developer opened at $5.62, hitting a high of $5.87 in mid-morning before sliding to a low of $4.76 in early afternoon. The stock recently changed hands at $5.07, down 11%, at approximately 2 p.m. ET.

On Wednesday, Blue Water announced it had closed on a previously announced private placement of 1.18M shares with options to buy up to 1.18 additional shares.

The price for one share plus one option was $6.775, with the option exercisable at $6.65 per share. The shares were priced at-the-market under Nasdaq rules.

Blue Water shares have been highly volatile since their market debut on Feb. 18, which saw its stock soar nearly 540%. The company offered 2.2M shares priced at $9 per share to raise around $20M.

The vaccine developer’s shares plunged on April 7 amid no apparent news and have been trading significantly below their IPO price since April 12. The private placement was announced on April 13.


Original article

Click here to view the original article

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Share on linkedin
LinkedIn
On Key

Related Posts